Core Viewpoint - RYVYL Inc. has announced a 1-for-35 reverse stock split to increase the market price per share of its common stock, ensuring compliance with Nasdaq listing requirements and making investments more attractive to investors [2][3]. Group 1: Reverse Stock Split Details - The reverse stock split will be legally effective on January 1, 2026, with trading on a split-adjusted basis starting January 2, 2026, under the existing symbol "RVYL" [3]. - Every 35 shares of common stock will be automatically reclassified into one new share, while the par value per share remains unchanged at $0.001 [3]. - No fractional shares will be issued; any resulting fractional shares will be rounded up to the nearest whole share [4]. Group 2: Shareholder Impact - Stockholders with shares in brokerage accounts will have their positions automatically adjusted without needing to take any action [5]. - Registered stockholders holding pre-split shares electronically will also not need to take any action to receive post-split shares [5]. Group 3: Company Overview - RYVYL Inc. operates in the digital payment processing sector, providing solutions for underserved markets and enabling global transactions [6]. - The company has developed a suite of financial products with enhanced security, data privacy, and rapid settlement capabilities [6].

Core Viewpoint - Adicet Bio, Inc. has announced a one-for-16 reverse stock split of its common stock to comply with Nasdaq listing requirements, effective December 30, 2025 [1][6]. Group 1: Reverse Stock Split Details - The reverse stock split will combine every sixteen shares of common stock into one share, reducing the outstanding shares from approximately 153.3 million to about 9.6 million [3]. - The par value per share will remain unchanged, and the total number of authorized shares will stay at 300 million, increasing the shares available for future issuance [3]. - Proportional adjustments will be made to equity incentive plans, stock options, and outstanding warrants to reflect the reverse stock split [4]. Group 2: Implementation and Impact - The reverse stock split will take effect at 12:01 a.m. Eastern Time on December 30, 2025, with trading on a split-adjusted basis commencing on the same day [2]. - Stockholders will not need to take any action, as the changes will be reflected in their accounts automatically [6]. - The primary goal of the reverse stock split is to help Adicet regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market [6]. Group 3: Company Overview - Adicet Bio, Inc. is a clinical stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer [7].

LA VERNE, CALIFORNIA / ACCESS Newswire / December 23, 2025 / Greenlite Ventures, Inc. (OTC Pink:GRNL) (the "Company") today announced that it will proceed with a 1-for- 200 reverse stock split of its Common Stock following approval by the Board of Directors and stockholders owning a majority of the voting shares on June 11, 2025. One of the primary goals of the reverse stock split is to increase the per-share price of the Company's Common Stock. ...

Core Viewpoint - Elong Power Holding Limited has announced a 16-for-1 reverse stock split to comply with Nasdaq's minimum bid price requirement, reducing its outstanding shares significantly from approximately 61.3 million to about 3.8 million [1][2][4]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect on December 26, 2026, with Class A ordinary shares trading under the existing ticker symbol "ELPW" [1]. - Following the reverse stock split, the par value of the ordinary shares will be adjusted to $0.00016 per share, and the number of authorized shares will be proportionately reduced [3]. - Outstanding warrants and options will also be adjusted proportionately, with no fractional shares issued; entitlements will be rounded up to the nearest whole share [5]. Group 2: Compliance and Strategic Intent - The reverse stock split is a strategic move to ensure compliance with Nasdaq's requirement of maintaining a minimum bid price of at least $1.00 per share [4]. - The company aims to enhance its market position and maintain its listing on the Nasdaq Capital Market through this action [4]. Group 3: Company Overview - Elong Power is focused on the research, development, manufacturing, and sales of high-power lithium-ion batteries for electric vehicles and energy storage systems [7]. - The company offers a comprehensive product portfolio that includes battery cells, modules, and management systems, catering to various high-power and energy storage applications [8].

Core Viewpoint - Robin Energy Ltd. has announced a one-for-five reverse stock split of its common shares, aimed at reducing the number of outstanding shares and potentially increasing the share price [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect at 11:59 pm Eastern Time on December 23, 2025, with trading on a split-adjusted basis starting on December 24, 2025 [2]. - The number of outstanding common shares will decrease from approximately 14.0 million to approximately 2.8 million as a result of the reverse stock split [3]. - No fractional shares will be issued; stockholders entitled to a fraction will receive a cash payment based on the closing price of the shares on December 23, 2025 [4]. Group 2: Shareholder Information - Stockholders with shares held in book-entry form or through a bank, broker, or other nominee will not need to take any action, as the effects of the reverse stock split will be reflected in their accounts after December 24, 2025 [5]. - The reverse stock split ratio has been approved by the board of directors and is within the range authorized by the stockholders [6]. Group 3: Company Overview - Robin Energy Ltd. is an international ship-owning company that provides energy transportation services globally, operating a fleet that includes two LPG carriers and one Handysize tanker vessel [7].

Speaking after RYVYL’s 2025 Annual Meeting of Shareholders, Heckman said Roundtable, RYVYL’s largest shareholder, voted its shares in favor of the proposals, and brought its investment up to $6.5 million, in advance of merger, to ensure shareholder equity compliant with Nasdaq. “Over 90% of shareholder voters agreed to increase the share price to maintain Nasdaq listing,” said James Heckman, CEO of Roundtable. “The Nasdaq listing is critical to shareholder value and the merger. Roundtable now believes all ...

Core Viewpoint - INNO HOLDINGS INC. has announced a 1-for-24 reverse stock split to comply with Nasdaq listing requirements and strengthen its capital structure [1][4]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of issued and outstanding shares from approximately 97,948,480 to about 4,081,187 shares [3]. - The reverse stock split will take effect on December 22, 2025, at 12:01 a.m. Eastern Time, and the common stock will continue to trade under the symbol "INHD" on a split-adjusted basis [2][3]. - Fractional shares will not be issued; instead, any fractional entitlements will be rounded up to the next highest whole number [3]. Group 2: Company Overview - INNO HOLDINGS INC. is a trade-focused electronic products trading company incorporated in Texas, with operations primarily in Hong Kong [5]. - The company aims to enhance its enterprise value and shareholder value by creating greater commercial value for its business partners [5]. - INNO has a professional brand and marketing management system to facilitate the connection and operation of marketing channels globally [5].

Core Viewpoint - Haoxin Holdings Limited has received a notification from Nasdaq regarding non-compliance with the Minimum Bid Price Requirement due to its Class A ordinary shares trading below US$1.00 for 31 consecutive business days [1][2]. Compliance Status - The closing bid price of the Company's Class A ordinary shares was below US$1.00 from October 30, 2025, to December 12, 2025 [2]. - The Company has a 180-calendar-day compliance period, ending on June 15, 2026, to regain compliance by maintaining a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days [2][3]. Options for Compliance - If the Company does not regain compliance within the initial period, it may be eligible for an additional 180-calendar-day compliance period, provided it meets other continued listing requirements and notifies Nasdaq of its intention to cure the deficiency [3]. - The Company is considering options such as a reverse stock split to regain compliance with the Minimum Bid Price Requirement [4]. Company Overview - Haoxin Holdings Limited provides temperature-controlled truckload transportation and urban delivery services in China, focusing on factory logistics for various goods including electronic devices, chemicals, and food [5]. - The Company's transportation network covers 30 out of 34 provinces and autonomous regions in China [5].

Core Insights - Sutro Biopharma, Inc. has regained compliance with Nasdaq's minimum share price requirement following a reverse stock split [1][2] Company Overview - Sutro Biopharma is a clinical-stage oncology company focused on developing site-specific and novel-format antibody drug conjugates (ADCs) [1][3] - The company aims to deliver single- and dual-payload ADCs to improve drug exposure, reduce side effects, and expand treatable tumor types [3] - Sutro's pipeline targets large oncology markets with significant unmet needs for improved therapies [3] Compliance with Nasdaq - As of December 16, 2025, Sutro's common stock maintained an average closing share price of at least $1.00 after a 1:10 reverse stock split effective December 3, 2025 [2] - The company is no longer considered below the minimum bid price requirement under Nasdaq Rule 5450(a)(1) [2]

Core Viewpoint - Aditxt Inc. (NASDAQ:ADTX) shares experienced a significant increase of 52.11% in after-hours trading, reaching $2.16, following the filing of a definitive proxy statement for a special stockholder virtual meeting scheduled for January 30, 2026 [1] Group 1: Shareholder Proposals - The proxy statement includes several key proposals that require shareholder approval, including compliance with Nasdaq Marketplace Rule 5635(d), which mandates shareholder approval for issuances exceeding 20% of outstanding shares at below-market prices [2] - Proposals involve the issuance of common stock related to Series A-1 Convertible Preferred Stock from December 2023, Series C-1 Convertible Preferred Stock and warrants from May and August 2024, and common stock purchase warrants from July 2024 [3] Group 2: Employee Incentives and Stock Split - Aditxt is seeking approval for its 2025 Employee Stock Purchase Plan, allowing employees to buy company stock at a discount through payroll deductions, and an amendment to the 2021 Omnibus Equity Incentive Plan, increasing the number of shares from 3 to 350,000 [3] - The board is requesting discretionary authority to implement a reverse stock split at a ratio between 1-for-5 and 1-for-250, with the specific ratio to be determined by the board within one year of stockholder approval [4] Group 3: Name Change and Advisory Vote - Stockholders will also vote on a non-binding advisory proposal to change the company name from "Aditxt, Inc." to "bitXbio, Inc." [5] - Kingsdale Advisors will act as the strategic stockholder advisor and proxy solicitation agent for the meeting [5] Group 4: Trading Metrics - Year-to-date, ADTX shares have declined by 99.97%, with a current market capitalization of $794,410 [6] - On the previous trading day, Aditxt shares closed down 1.39% at $1.42, and the stock has a negative price trend across all time frames according to Benzinga's Edge Stock Rankings [6]